Rivus to Present Animal Study on GLP-1's Muscle-Sparing Effects | Retatrutide News

Rivus Pharmaceuticals will present animal data on a GLP-1 agonist with muscle-sparing properties. This could impact the development of GLP-1 drugs like ...
Clinical Trials · October 31, 2026